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Abstract: Two hypotheses explain the role of adult progenitor cells in myocardial regeneration. Stem cell plasticity which
involves mobilization of stem cells from the bone marrow and other niches, homing to the area of tissue injury and
transdifferentiation into functional cardiomyocytes. Alternative hypothesis is based on the observations that bone marrow
harbors a heterogenous population of cells positive for CXCR4 - receptor for chemokine SDF-1. This population of
non-hematopoietic cells expresses genes specific for early muscle, myocardial and endothelial progenitor cells (EPC). These
tissue-committed stem cells circulate in the peripheral blood at low numbers and can be mobilized by hematopoietic cytokines
in the setting of myocardial ischemia. Endothelial precursors capable of transforming into mature, functional endothelial cells
are present in the pool of peripheral mononuclear cells in circulation. Their number significantly increases in acute myocardial
infarction (AMI) with subsequent decrease after 1 month, as well as in patients with unstable angina in comparison to stable
coronary heart disease (CHD). There are numerous physiological and pathological stimuli which influence the number of
circulating EPC such as regular physical activity, medications (statins, PPAR-γ agonists, estrogens), as well as numerous
inflammatory and hematopoietic cytokines. Mobilization of stem cells in AMI involves not only the endothelial progenitors
but also hematopoietic, non-hematopoietic stem cells and most probably the mesenchymal cells. In healthy subjects and patients
with stable CHD, small number of circulating CD34+, CXCR4+, CD117+, c-met+ and CD34/CD117+ stem cells can be detected.
In patients with AMI, a significant increase in CD34+/CXCR4+, CD117+, c-met+ and CD34/CD117+ stem cell number the in
peripheral blood was demonstrated with parallel increase in mRNA expression for early cardiac, muscle and endothelial
markers in peripheral blood mononuclear cells. The maximum number of stem cells was found early in ST-segment elevation
myocardial infarction (<12 hours) with subsequent decrease through the 7-day follow-up and with concomitant changes in the
levels of cytokines involved in the inflammatory response and stem cell recruitment. Moreover, peak expression of cardiac
muscle and endothelial markers occurred at the same time as the most significant increase in CD34/CXCR4+ stem cell number.
The SDF-1/CXCR-4 axis seems particularly important in stem/muscle progenitor cell homing, chemotaxis, engraftment and
retention in ischaemic myocardium. The significance of autologous stem cells mobilization in terms of cardiac salvage and
regeneration needs to be proved in humans but it seems to be a reparative mechanism triggered early in the course of acute
coronary syndromes.
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Introduction
Numerous animal models of acute myocardial infarction
as well as clinical trials involving intracoronary infusion of
bone marrow and peripheral blood-derived autologous
progenitor cells have documented that these cells may have
the potential to regenerate or/and improve function of the
myocardium after the ischaemic injury [3, 4, 17]. 
Two hypotheses explain the role of adult progenitor
cells in tissue regeneration. Stem cell plasticity involves
the increase of hematopoietic cytokines with subsequent
mobilization of stem cells from the bone marrow and
other niches (e.g. skeletal muscles), homing to the area
of tissue injury and transdifferentiation into functional
cardiomyocytes [11]. Alternative hypothesis was for-
mulated, which is based on the observations that bone
marrow harbors a heterogenous population of cells
positive for CXCR4 - receptor for chemokine stromal
cell-derived factor-1 (SDF-1). This population of
non-hematopoietic cells expresses genes specific for
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early muscle, myocardial and endothelial progenitor
cells [10]. These tissue-committed stem cells (TCSC)
circulate in the peripheral blood at low numbers and can
be mobilized by hematopoietic cytokines in the setting
of vascular injury, ischemia and after cytokine stimula-
tion [9, 20]. Evidence that migratory cells participate in
the formation of virtually all cardiac structures in trans-
planted heart comes from work of Quaini et al. docu-
menting the systemic chimerism in cases in which a male
patient received a heart from a female [14]. The signi-
ficance of autologous stem cell mobilization in terms of
cardiac salvage and regeneration needs to be proved in
humans but it seems to be a reparative mechanism
triggered early in the course of acute coronary syn-
dromes (ACS).
Mobilization of endothelial progenitor cells
(EPC)
Endothelial precursors capable of transforming into ma-
ture, functional endothelial cells are present in the pool
of peripheral mononuclear cells in circulation [1]. Shin-
tani et al. [16] described for the first time a significant
increase in CD34+ peripheral blood mononuclear cells
(PBMNC) positive for lineage markers (KDR, VE-cad-
herin, CD31) as well as function (Dil-acLDL uptake)
and morphology of EPC. The number of EPC peaked
after 1 week after acute myocardial infarction (AMI)
with subsequent decrease after 1 month. Conversely,
according to Masa et al. [13], the peak mobilization of
EPC occurs early (hours) in AMI. These findings were
confirmed by George and coworkers by assessing of the
EPC number in patients with unstable angina in com-
parison to stable coronary heart disease (CHD). They
demonstrated increased number of circulating EPC with
typical immunophenotype and functional properties in
patients with unstable angina. In 3 months-follow-up,
the number of EPCs was reduced by 50% in comparison
to baseline counts. Moreover, a positive correlation was
found between systemic C-reactive protein levels and
circulating EPC [5]. Both studies give an important
message because recent data from both experimental
and clinical studies show that EPC can potentially be
used for therapeutic angiogenesis resulting in the im-
provement of myocardial function. The spontaneous
mobilization of these cells in AMI and unstable angina
may be an important reparatory mechanism [1, 5]. 
There are numerous physiological and pathological
stimuli which influence the number of circulating EPC,
as shown in Table 1.
Mobilization of tissue-committed stem cells
Mobilization of stem cells in AMI involves not only the
endothelial progenitors but also hematopoietic, non-he-
matopoietic stem cells and most probably the mesenchy-
mal cells [4, 9, 20]. In healthy subjects and patients with
stable CHD, small number of circulating CD34+,
CXCR4+, CD117+, c-met+ and CD34/CD117+ stem cells
can be detected. In patients with AMI, a significant
increase in CD34+/CXCR4+, CD117+, c-met+ and
CD34/CD117+ stem cell number the in peripheral blood
was demonstrated with parallel increase in mRNA ex-
pression for early cardiac, muscle and endothelial mar-
kers in PBNMC. The maximum number of stem cells
was found early in ST-segment elevation myocardial
infarction (STEMI, <12 hours) with subsequent de-
crease through the 7-day follow-up with concomitant
changes in the levels of cytokines involved in the inflam-
matory response and stem cell recruitment. Moreover,
peak expression of cardiac muscle and endothelial mar-
kers in PBMNC occurred at the same time as the most
significant increase in CD34/CXCR4+ stem cell number
[20].
Massa et al. [13] demonstrated approx. 6 hours from
the onset of AMI a significant 5.8-fold increase in
CD34+ (both % of leukocytes and absolute number of
cells) mononuclear cells including both hematopoietic
Table 1. Factors influencing the mobilization of bone marrow pro-
genitor cells [9,14-20]
Factor Change in cpc number/function
Physical activity Increase
Age Decrease with age

































 PPAR-γ - peroxisome proliferator-activated receptor gamma; SDF-1
- stromal cell-derived factor-1; HGF - hepatocyte growth factor; LIF
- leukemia inhibitory factor
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progenitor and endothelial progenitor cells which grad-
ually declined to baseline within 2 months in comparison
to patients with stable angina and healthy controls.
Since these studies demonstrated a significant in-
crease in circulating hematopoietic and endothelial pro-
genitor cells peaking early - already a few hours after the
onset of symptoms of AMI, it seems that this phenome-
non is independent of the medical treatment and invasive
interventions the patients received. 
The SDF-1/CXCR-4 axis seems particularly import-
ant in stem/muscle progenitor cell homing, chemotaxis,
engraftment and retention in ischaemic myocardium.
Kucia et al. [9] showed that murine bone marrow con-
tains pool of cells that express early cardiac lineage
markers (Nkx2.5/Csx, GATA-4, and MEF2C) and can
be mobilized in experimental myocardial infarction.
Flow cytometry analysis revealed that cells expressing
these markers are nonadherent, nonhematopoietic cells
of the following immonophenotype: CXCR4+/Sca-1+/
lin-/CD45 in mice and CXCR4+/CD34+/AC133+/CD45-
in humans. These cells are mobilized into the peripheral
blood after myocardial infarction and chemoattracted to
the infarcted myocardium by SDF-1/CXCR4, HGF/c-
met and LIF-LIF-R (leukemia inhibitory factor/ leuke-
mia inhibitory factor receptor) axes [9]. This is the first
proof that the postnatal bone marrow contains nonhema-
topoietic population of cells that express markers for
cardiac differentiation [9-11]. 
Mobilization of stem cells in relation to clinical
and laboratory parameters
In patients with STEMI, low left ventricular ejection
fraction (LVEF) and high NT-proBNP levels (both in-
dependent predictors of clinical outcome), the mobiliza-
tion of stem cells expressing CD34, CXCR4 and c-met
antigens is significantly lower in comparison to patients
with LVEF > 40% and low levels of NT-proBNP. More-
over, the number of mobilized stem cells was negatively
correlated with cardiac necrosis markers (troponin I,
CK-MB) [19]. 
Further questions 
Despite of huge progress in understanding of bone mar-
row-derived cell (BMC) mobilization, much more ques-
tions remain to answered, e.g. is the mobilization of
BMC in acute coronary syndromes the reparatory re-
sponse leading to a significant myocardial salvage or just
a nonspecific inflammatory reaction? Furthermore, so
far no large clinical trials showed benefits from mobili-
zation of EPC using exogenous cytokines in patients
with AMI.
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